中/EN Contact/Message
Innovate
Daybue
Daybue
departments:神经内科
drug:口服溶液
Active:trofinetide
indication:治疗2岁及以上雷特综合征患者
Licensor:Acadia Pharmaceuticals Inc.
Approved Country/Region:FDA
Approval time:2023-03-10